Novartis has received FDA accelerated approval for Scemblix (asciminib) to treat adults with newly diagnosed Ph+ CML-CP.

In bestowing the pro-housing label on San Francisco, the Department of Housing and Community Development (HCD) said the city ...

On July 22, 2024, the Knesset’s Foreign Affairs and Defense Committee approved in the first reading three bills: the first ...

The registrational trial is expected to support the approval for Bavarian’s mpox/smallpox vaccine use in children between two ...

Vazalore is currently the only FDA-approved human aspirin that may be used in food-producing animals under certain conditions ...

Festival of Lights is not only a time for celebration; it’s also the perfect occasion to adorn yourself with stunning ...

Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a wide variety ...

Previously, Avery Dennison’s standard adhesion film labels were in limited compatibility for the colored HDPE recycling ...

The Upper East Regional Office of the Food and Drugs Authority (FDA), says a type of Postinor 2 with a pink flower label on ...

The Upper East Regional Office of the Food and Drugs Authority (FDA), says a type of Postinor 2 with pink flower label on the ...